期刊文献+

低位直肠癌术前放疗联合化疗的疗效观察 被引量:10

Combined preoperative chemotherapy with radiotherapy for lower rectal cancer
原文传递
导出
摘要 目的探讨术前化疗联合放疗在低位直肠癌治疗中的疗效。方法将70例低位直肠癌患者随机分为两组:单纯手术组进行常规手术治疗;综合治疗组予以卡培他滨口服和放疗后再手术。结果综合治疗组于放化疗结束后检查发现肿块均有不同程度缩小、活动度增加,下极距肛缘的距离延长0.8~1.5(平均1.2)cm;手术切除标本见大片坏死组织、细胞变性、癌周浸润消失以及肿块旁淋巴结大部分坏死和癌周血管闭塞。综合治疗组和单纯手术组的手术切除率分别为80.0%和100%,两组比较P<0.05;保肛率分别为34.3%和82.9%,两组比较P<0.01;局部复发率分别为17.9%和0,两组比较P<0.05;差异均有显著性意义。结论术前卡培他滨联合放疗对于低位直肠癌是目前较好的新辅助治疗方案。 Objective To explore the effect of combined preoperative chemotherapy with radiotherapy for lower rectal carcinoma. Methods Seventy patients with lower rectal cancer were randomly divided into two groups. Thirty five patients in group A were treated with operation alone and other 35 patients in group B received combined chemotherapy of capecitabine with radiotherapy before operation. Results After neoadjuvant therapy,the tumors became smaller and more movable,and the distance from the lower edge of the tumor to the anal level was extended 0.8 to 1.5 cm. Postoperative pathological examination of surgical specimens revealed tumor tissue necrosis,paratumor infiltration disappearance,paratumor lymph node necrosis and blood vessel occlusion. The resection rates were 80.0%and 100%(P< 0.05),anal preservation rates were 34.3%and 82.9%(P< 0.01), and local recurrence rates were 17.9%and 0(P< 0.05) respectively in group A and group B. Conclusion Combined preoperative chemotherapy with radiotherapy is a better neoadjuvant therapy for lower rectal carcinoma.
出处 《中华胃肠外科杂志》 CAS 2004年第5期378-380,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 低位直肠癌 综合治疗 术前放疗 肿块 卡培他滨 联合放疗 联合化疗 Low rectal neoplasms Chemotherapy Radiotherapy Neoadjuvant therapy
  • 相关文献

参考文献12

  • 1Burke SJ, Percarpio BA, Knight DC, et al. Combined preoperative radiation and mitomycin/5-fluorouracil treatment for locally advanced rectal adenocarcinoma. J Am Coll Surg, 1998, 187: 164-170.
  • 2Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent rectal cancer response to preoperative radiation and chemotherapy. Ann Surg, 2002, 236: 75-81.
  • 3中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范第4分册.第2版.北京:北京医科大学中国协和医科大学联合出版社,1991.50-51.
  • 4潘宏铭,徐农,耿宝琴,等.肿瘤内科诊治策略.上海:上海科学技术出版社,2002.428-429.
  • 5Penna C, Nordlinger B. Colorectal metastasis (liver and lung) .Surg Clin North Am, 2002, 82: 1075-1090.
  • 6Penna C, Nordlinger B. Surgery of liver metastases from colorectal cancer: new promises. Br Med Bull, 2002, 64: 127-140.
  • 7Law WL, Chu KW. Resection of local recurrence of rectal cancer:results. World J Surg, 2000, 24: 486-490.
  • 8Rodel C, Grabonbauer GG, Matzel KE, et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis colon Rectum, 2000, 43:312-319.
  • 9董全地,赵仲生.大肠癌术前动脉插管化疗疗效分析[J].中国肛肠病杂志,1999,19(4):22-23. 被引量:3
  • 10Sawada N, Ishikawa T, Sekiguchi F, et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Chin Cancer Res, 1999, 5: 2948-2953.

二级参考文献5

  • 1[1]Minsky BD. Adjuvant therapy for rectal cancer:results and controversies[J]. Oncology, 1998,12(8): 1129-1139.
  • 2[2]Bosset JF,Magnin V, Maingon P, et al. Preoperative radiochemotherapy in rectal cancer: long term results of a phase Ⅱ trial[J]. Int J Radiat Oncol Biol Phys,2000,46(2):323-327.
  • 3[3]Foo KF, Micheal M, Zalcberg J. Adjuvant theraphy for rectal cancer[J]. Semin Colon Rectum Surg, 2002,13(4):259-268.
  • 4[4]Sawada N, Ishikawa T, Sakiguchi F, et al. X-ray irradiati on induces thymidine phosphorylase and enhances the efficacy of capecitabine(Xeloda) in human cancer xenografts [J]. Clin Cancer Res, 1999,5:2948-2953.
  • 5张效儒,石景森,刘绍诰.青年大肠癌107例临床病理分析[J]陕西新医药,1981(07).

共引文献19

同被引文献102

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部